Accession Number : AD1012682


Title :   Periodontal Regeneration Of 1-, 2-, and 3-Walled Intrabony Defects Using Accell Connexus (registered trademark) Versus Demineralized Freeze-Dried Bone Allograft: A Randomized Parallel Arm Clinical Control Trial


Descriptive Note : Technical Report


Corporate Author : Uniformed Services University Of The Health Sciences Bethesda United States


Personal Author(s) : Alston,Teresita L


Full Text : https://apps.dtic.mil/dtic/tr/fulltext/u2/1012682.pdf


Report Date : 01 Jun 2015


Pagination or Media Count : 99


Abstract : Combination therapy, in guided tissue regeneration (GTR), is often used in the treatment of intrabony defects. Particulate demineralized freeze- dried bone allograft (DFDBA) is a bone grafting materials used successfully in GTR on humans for almost 30 years. A newer form of DFDBA, Accell Connexus (Accell), has been FDA approved for use in periodontal regeneration which is the growth of new bone, cementum and periodontal ligament on a previously diseased tooth root surface. Accell Connexus contains 5-7 times more bone morphogenic proteins (BMP) than the traditional particulate DFDBA. This increase in BMP is thought to increase the potential of periodontal regeneration.


Descriptors :   GRAFTS , Regeneration (Physiology) , Dental surgery


Distribution Statement : APPROVED FOR PUBLIC RELEASE